Cell-Line–Specific Cytotoxic and Antiproliferative Effects of Citrinin in A549 and HCT-116 Cells
Abstract
Citrinin (CIT) is a mycotoxin commonly found in foods and has been linked to toxicity in various cell types. In our study, we examined how CIT affects human lung adenocarcinoma (A549), colorectal cancer (HCT116), and healthy fibroblast (L929, used as a control) cells. Our MTS assays revealed that CIT reduced cell viability in a manner dependent on both dose and exposure time. Interestingly, HCT116 cells were more sensitive to CIT than A549 cells, suggesting that its effects can vary between cancer types. We also performed wound healing experiments to assess cell migration and proliferation. CIT significantly slowed these processes in cancer cells, while fibroblasts were less affected. These results indicate that CIT can hinder cancer cell spread, though not without affecting normal cells. Previous studies have proposed several mechanisms for CIT’s toxicity. It appears to promote apoptosis by generating reactive oxygen species, disrupting mitochondrial membrane potential, activating caspases, and inducing endoplasmic reticulum stress. While these anticancer effects are promising, CIT’s high toxicity to normal cells and limited selectivity remain major hurdles for therapeutic use. Overall, our findings shed light on CIT’s cytotoxic and antimigratory actions, emphasizing the need for further research to identify doses that maximize its anticancer potential while minimizing harm to healthy cells.
Keywords
Citrinin, Cytotoxicity, Cell Migration, A549, HCT116, MTS
Supporting Institution
This study was supported by the TÜBİTAK 2209-A University Students Research Projects Support Program.
Project Number
This study was supported by the TÜBİTAK 2209-A University Students Research Projects Support Program.
Ethical Statement
Studies conducted on laboratory-cultured cell lines do not require ethical approval.
References
- [1] Yüce H, Ünüvar S. Mikotoksinlerin in vitro ve in vivo antikanser aktivitelerinin değerlendirilmesi. J Lit Pharm Sci. 2022;11(2):143–151.
- [2] Bennett JW, Klich M. Mycotoxins. Clin Microbiol Rev. 2003;16(3):497–516.
- [3] Shekhar R, Raghavendra VB, Rachitha P. A comprehensive review of mycotoxins, their toxicity, and innovative detoxification methods. Toxicol Rep. 2025;14:101952.
- [4] Silva LJG, Pereira AMPT, Pena A, Lino CM. Citrinin in foods and supplements: A review of occurrence and analytical methodologies. Foods. 2020;10(1):14.
- [5] Kamle M, Mahato DK, Gupta A, Pandhi S, et al. Citrinin mycotoxin contamination in food and feed: Impact on agriculture, human health, and detection and management strategies. Toxins (Basel). 2022;14(2):85.
- [6] Vrabcheva T, Usleber E, Dietrich R, Märtlbauer E. Co-occurrence of ochratoxin A and citrinin in cereals from Bulgarian villages with a history of Balkan endemic nephropathy. J Agric Food Chem. 2000;48(6):2483–2488.
- [7] Wu D, Yang C, Yang M, Wu Y, et al. Citrinin-induced hepatotoxicity in mice is regulated by the Ca²⁺/endoplasmic reticulum stress signaling pathway. Toxins (Basel). 2022;14(4):259.
- [8] Bouslimi A, Bouaziz C, Ayed-Boussema I, Hassen W, Bacha H. Individual and combined effects of ochratoxin A and citrinin on viability and DNA fragmentation in cultured Vero cells and on chromosome aberrations in mice bone marrow cells. Toxicology. 2008;251(1–3):1–7.
- [9] Yu FY, Liao YC, Chang CH, Liu BH. Citrinin induces apoptosis in HL-60 cells via activation of the mitochondrial pathway. Toxicol Lett. 2006;161(2):143–151.
- [10] Skrzydlewski P, Twarużek M, Grajewski J. Cytotoxicity of mycotoxins and their combinations on different cell lines: A review. Toxins (Basel). 2022;14(4):244.